ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Microscope-Free Analyte Detection Based on Fiber-Optic Gliding Motility Assays.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Microscope-Free Analyte Detection Based on Fiber-Optic Gliding Motility Assays.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Lowering Ionic Strength Improves the Sensitivity of Microtubule Gliding Assay Based Molecular Detection.Nano letters · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Prolonged hospital waiting times are linked with increased patient mortality and cause additional financial burdens on institutions. Efficient point-of-care diagnosis would help alleviate this, but is hampered by a lack of cost-effective devices capable of rapid, in situ, wide ranging analyte detection. Lab-on-fiber technology provides an answer allowing for diagnosis, treatment, and monitoring in situ with real time feedback. Here, a device is demonstrated that harnesses motor-protein-driven-microtubule molecular detection assays to optical fibers. By developing a new method for microscope-free microtubule gliding speed determination, proof of concept is demonstrated in the detection of Monomeric Streptavidin and Neutravidin, which initiate a decrease in speed in biotinylated microtubules as well as bundling in the latter case. Utilizing antibody functionalizsed microtubules label-free and microscope-free detection of the heart attack marker Creatine Kinase-MB, as well secondary antibodies in nm concentration is demonstrated. This detector has the potential to be used in situ, providing rapid, low-cost, multiplex analyte screening and detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.